Growth differentiation factor-15 as a potential biomarker in subclinical inflammation in familial mediterranean fever
Clinical Rheumatology · 2026
DOI: 10.1007/s10067-026-08064-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2026. Verfasst von Osman Cure und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Faculty of Medicine, Recep Tayyip Erdogan University, 53000, Rize, Türkiye. osman.cure@erdogan.edu.tr. Hauptthemen laut MEDLINE: Familial Mediterranean Fever, Growth Differentiation Factor 15, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Recep Tayyip Erdogan Üniversitesi, Recep Tayyip Erdoğan University.
Abstract (Originalsprache)
Objectives
This study aimed to investigate whether growth differentiation factor-15 (GDF-15) can serve as a potential biomarker for assessing subclinical inflammation during the attack-free (intercritical) period in patients with familial Mediterranean fever (FMF).
Methods
In a single-center cross-sectional case–control study, 52 FMF patients in the attack-free period were compared with 52 age- and sex-matched healthy controls. ELISA measured serum GDF-15 levels; acute-phase reactants (CRP, ESR, SAA, fibrinogen) and various hematologic inflammation indices were evaluated. Statistical analyses included the Mann–Whitney U, chi-square, Kruskal–Wallis, Spearman correlation, and ROC curve methods.
Results
Serum GDF-15 levels were significantly higher in the FMF group than in controls ( p < 0.001). Subclinical inflammation, defined by SAA > 10 mg/L, was detected in 78.8% of FMF patients. GDF-15 correlated positively with CRP and SAA ( p < 0.05). GDF-15 levels did not differ across MEFV mutation subgroups or by the presence of the M694V mutation. Patients with subclinical inflammation had significantly higher GDF-15 levels than those without. ROC analysis showed that GDF-15 had a statistically significant ability to distinguish FMF from controls (AUC = 0.78; p < 0.001) and to identify subclinical inflammation (AUC = 0.74; p = 0.014).
Conclusion
GDF-15 appears to be a potential biomarker reflecting ongoing subclinical inflammation during the attack-free period in FMF. Elevated GDF-15 levels in patients with SAA-defined subclinical inflammation suggest that GDF-15 may reflect low-grade inflammatory activity. Larger studies are needed to validate these findings. Key Points • Serum GDF-15 was significantly higher in the attack-free FMF patients than in controls, supporting its potential to reflect persistent low-grade (subclinical) inflammation. • GDF-15 showed moderate discriminative performance (AUC 0.783) and may complement conventional acute-phase reactants in assessing inflammatory burden during attack-free periods. • GDF-15 levels did not differ significantly across MEFV mutation subgroups or by M694V status in this cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Faculty of Medicine, Recep Tayyip Erdogan University, 53000, Rize, Türkiye. osman.cure@erdogan.edu.tr.
- Department of Medical Biochemistry, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Türkiye.
- Department of Urology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Türkiye.
- Department of Medical Biochemistry, Graduate School of Health Sciences, Karadeniz Technical University, Trabzon, Türkiye.
- Department of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Türkiye.
Förderung
- Recep Tayyip Erdogan Üniversitesi
- Recep Tayyip Erdoğan University
Zitieren
APA
Cure, O., Huner Yigit, M., Uzun, H., Zihni, H. C., & Yigit, E. (2026). Growth differentiation factor-15 as a potential biomarker in subclinical inflammation in familial mediterranean fever. Clinical Rheumatology. https://doi.org/10.1007/s10067-026-08064-4
Vancouver
Cure O, Huner Yigit M, Uzun H, Zihni HC, Yigit E. Growth differentiation factor-15 as a potential biomarker in subclinical inflammation in familial mediterranean fever. Clinical Rheumatology. 2026. doi:10.1007/s10067-026-08064-4
BibTeX
@article{Cure2026,
author = {Cure, Osman and Huner Yigit, Merve and Uzun, Hakki and Zihni, Huseyin Cinar and Yigit, Ertugrul},
title = {Growth differentiation factor-15 as a potential biomarker in subclinical inflammation in familial mediterranean fever},
journal = {Clinical Rheumatology},
year = {2026},
doi = {10.1007/s10067-026-08064-4}
}
EUVIMED